266 related articles for article (PubMed ID: 11365016)
1. An evaluation of drug cocktail combinations for their immunological value in preventing/remitting opportunistic infections.
Konlee M
Posit Health News; 1998; (No 16):2-4. PubMed ID: 11365016
[TBL] [Abstract][Full Text] [Related]
2. To AIDS and back with Norvir, D4T, 3TC and nutritional therapies. An interview with Michael Golk.
Golk M
Posit Health News; 1998; (No 16):5-7. PubMed ID: 11365018
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy for patients with HIV-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents.
Gulick R
AIDS; 1998; 12 Suppl 3():S17-22. PubMed ID: 15168719
[TBL] [Abstract][Full Text] [Related]
5. The end of AIDS?
Leland J
Newsweek; 1996 Dec; 128(23):64-8, 71, 73. PubMed ID: 10162943
[No Abstract] [Full Text] [Related]
6. Protease inhibitors at a glance...
Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198
[TBL] [Abstract][Full Text] [Related]
7. The new antiretroviral arsenal.
Smith D
AIDS Treat News; 1996 Nov; (No 259):4-5. PubMed ID: 11364001
[TBL] [Abstract][Full Text] [Related]
8. Nonnucleoside reverse transcriptase inhibitors.
Murphy RL
AIDS Clin Care; 1997 Oct; 9(10):75-7, 79. PubMed ID: 11364757
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.
Krogstad P; Lee S; Johnson G; Stanley K; McNamara J; Moye J; Jackson JB; Aguayo R; Dieudonne A; Khoury M; Mendez H; Nachman S; Wiznia A;
Clin Infect Dis; 2002 Apr; 34(7):991-1001. PubMed ID: 11880966
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy danger.
Posit Aware; 1998; 9(5):18. PubMed ID: 11365886
[TBL] [Abstract][Full Text] [Related]
11. 3TC approval may revive AZT's appeal.
Vazquez E
Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
[TBL] [Abstract][Full Text] [Related]
12. Anti-HIV drug update.
Proj Inf Perspect; 2000 Aug; (30):5-6. PubMed ID: 12171015
[TBL] [Abstract][Full Text] [Related]
13. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
Cardiello P; Srasuebkul P; Hassink E; Mahanontharit A; Samor T; Ruxrungtham K; Lange J; Cooper D; Phanuphak P
HIV Med; 2005 Mar; 6(2):122-8. PubMed ID: 15807718
[TBL] [Abstract][Full Text] [Related]
14. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
Guo JJ; Jang R; Louder A; Cluxton RJ
Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
[TBL] [Abstract][Full Text] [Related]
15. [AIDS triple therapy. The gap between viral load and side effects].
Gürtler L
Fortschr Med; 1998 Sep; 116(27):4-5. PubMed ID: 9816747
[No Abstract] [Full Text] [Related]
16. [Drug combination therapy for children infected with HIV/AIDS--own experience].
Prandota-Schoepp A; Klinowska-Skupniewska J
Przegl Epidemiol; 2001; 55 Suppl 3():135-41. PubMed ID: 11984940
[TBL] [Abstract][Full Text] [Related]
17. Standard treatments for HIV, Spring 1997.
Smith D
AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255
[TBL] [Abstract][Full Text] [Related]
18. [Non-nucleoside reverse transcriptase inhibitor as a fully viable alternative. Strong therapy start without protease inhibitor].
MMW Fortschr Med; 2000 Mar; 142 Suppl 1():30-3. PubMed ID: 10863307
[No Abstract] [Full Text] [Related]
19. Delavirdine (Rescriptor) approved.
James JS
AIDS Treat News; 1997 Apr; (No 269):1-3. PubMed ID: 11364252
[TBL] [Abstract][Full Text] [Related]
20. For people needing a new drug.
Vazquez E
Posit Aware; 1999; 10(2):45-6. PubMed ID: 11366852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
